Bio-Rad Laboratories | BIO - Loan Capital


Bio-Rad Laboratories reported $1.2B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Abbott USD 11.6B 1.33B Sep/2025
Agilent USD 3.05B 300M Sep/2025
Becton, Dickinson and Co. USD 17.62B 90M Sep/2025
Bio Techne USD 260M 40M Dec/2025
Bio-Rad Laboratories USD 1.2B 300K Sep/2025
Bruker USD 1.98B 395.4M Sep/2025
Charles River Laboratories USD 2.19B 146.92M Sep/2025
Danaher USD 18.42B 1.58B Dec/2025
Exact Sciences USD 2.33B 9.34M Sep/2025
General Electric Aerospace USD 18.81B 37M Dec/2025
Hologic USD 2.5B 2.1M Dec/2025
Illumina USD 1.49B 496M Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Laboratory Of America USD 5.15B 3.9M Sep/2025
Merck USD 39.97B 6B Sep/2025
Mettler Toledo International USD 2.09B 58.01M Dec/2025
Myriad Genetics USD 119.5M 60.2M Sep/2025
Quest Diagnostics USD 5.17B 2M Sep/2025
Repligen USD 537.93M 4.2M Sep/2025
Revvity USD 2.63B 583.63M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025
Siemens EUR 44.84B 1.61B Sep/2025
Standard Biotools USD 299K 0 Sep/2025
Thermo Fisher Scientific USD 35.85B 4B Dec/2025
Tosoh JPY 74.39B 22.26B Dec/2025
Waters USD 947.21M 249.76M Sep/2025